Group 1: Trade Performance - In the first seven months of the year, China's goods trade import and export totaled 25.7 trillion yuan, a year-on-year increase of 3.5% [1] - In July alone, the total value of goods trade reached 3.91 trillion yuan, growing by 6.7% year-on-year [1] - High-tech and high-value-added products have become the main drivers of trade growth [1] Group 2: Structural Changes - Trade diversification has shown significant results, with rapid growth in trade with emerging markets such as Southeast Asia and Africa [1] - The number of trade entities has expanded, with private enterprises maintaining their position as the main force in foreign trade [1] - Service trade has achieved breakthrough growth, with knowledge-intensive services maintaining a surplus [1] Group 3: Regional Contributions - Zhejiang province's cross-border e-commerce ecosystem supported foreign trade development, with a total import and export value of 2.73 trillion yuan in the first half of the year, up 6.6% [1] - Fujian's foreign trade is driven by new energy and basic materials, with lithium battery exports reaching 76.461 billion yuan, a year-on-year increase of 23.96% [1] Group 4: Challenges and Future Outlook - High concentration in export markets, similar industrial structures, and severe homogenization competition remain persistent issues for China's foreign trade [2] - There is a need for multi-faceted measures to maintain stable and progressive foreign trade, enhancing quality and quantity [2] - Emphasis on increasing technological content in products and supporting strategic emerging industries through R&D and financing [2] Group 5: Service Trade and Digitalization - Encouragement for "China services" to go global, supporting the integration of service trade with goods trade [3] - Development of overseas logistics platforms and warehouses to enhance local service capabilities of Chinese brands [3] - Establishment of a digital comprehensive service platform for offshore trade to streamline data and regulatory processes [3] Group 6: Global Governance and Standards - Active participation in global economic governance to enhance China's voice in international trade rule-making [4] - Support for a multilateral trade system centered around the World Trade Organization and participation in emerging topics like digital trade [4] - Encouragement for domestic enterprises and industry associations to engage in international standardization activities [4]

上海自贸区数据出境负面清单成果初现：已形成4个使用案例 鉴于数据出境安全管理工作领域新、涉及行业面广、专业性强，浦东新区组建了一支数据跨境便利化服 务改革专家组，遴选了一批网络数据安全技术服务支撑单位，助力企业拓展海外市场。 专家组团队持续"扩容"。当日活动现场，来自上海市信息安全测评认证中心、上海数据交易所、中国电 信上海公司、数风科技有限公司等单位的第二批专家代表接受了聘书，6家专业机构接受了网络数据安 全技术服务支撑单位证书。(完) 中新网上海9月17日电 (记者 李姝徵)中国(上海)自由贸易试验区(以下简称上海自贸区)探索数据出境负面 清单见实效。 记者17日从自贸区数据出境负面清单实践交流活动暨2025年国家网络安全宣传周浦东新区活动启动仪式 上获悉，自2月8日《中国(上海)自由贸易试验区及临港新片区数据出境管理清单(负面清单)(2024版)》 (以下简称《负面清单》)公布以来，浦东新区已在再保险、医药领域形成4个负面清单使用案例，在风 险可控的前提下有效降低了企业数据出境的合规成本。 数据跨境流动正在逐步超过贸易、投资全球化，成为驱动全球经济增长的新动能。北京、上海、海南等 多地自贸区在数据跨境流 ...

数据出境负面清单对企业是机遇还是挑战？自贸区企业"现身说法"，政府答疑解惑再送"智囊团"。 9月17日，自贸区数据出境负面清单实践交流活动暨2025年国家网络安全宣传周浦东新区活动启动 仪式在上海自贸区金桥片区举行。江苏自贸区、浙江自贸区、上海市和浦东新区相关部门以及50余家重 点企业参加活动。 今年，我国各地自贸区纷纷构建数据出境负面清单。通过半年探索，上海自贸区率先召开全国首场 自贸区数据出境负面清单政策实践交流活动，不仅请来"国家队"指点迷津，还有兄弟省市单位分享经 验，更有企业"现身说法"。大家通过差异化互补，助力形成数据出境全国"一盘棋"。 此外，在任敏敏看来，负面清单还降低了企业合规成本，"以药物警戒场景为例，敏感个人信息触 发安全评估的阈值从1万人提高至10万人，大幅削减了合规成本，使企业能在合法合规前提下实现高效 数据流动"。 上海自贸区企业大胆探索实践的背后，离不开专业力量的支撑与指导。 今年2月清单公布后，上海自贸试验区保税区、陆家嘴、金桥、张江、世博五大片区数据跨境服务 中心正式成立。至今已累计开展近20场政策宣讲和申报指导活动，一对一接待解答企业咨询74家次，服 务辖区企业1000余家 ...

Core Viewpoint - The article discusses the "Development Plan for Open Innovation of the Biopharmaceutical Industry Chain in the China (Jiangsu) Pilot Free Trade Zone," which aims to enhance the biopharmaceutical industry's innovation capabilities and modernize its supply chain by 2030 [2]. Group 1: Key Objectives and Tasks - The plan includes 7 key areas and 18 specific tasks focused on integrated innovation across the entire biopharmaceutical industry chain [2]. - By 2030, the goal is to achieve rapid growth in the biopharmaceutical industry scale, optimize the innovation ecosystem, and significantly enhance the modernization level of the industry chain [2]. Group 2: R&D and Innovation - The plan emphasizes the importance of R&D innovation, particularly in advanced treatment methods such as immunotherapy, stem cell therapy, and gene therapy [4]. - It proposes measures to strengthen the application of big data and artificial intelligence in drug design and medical device manufacturing [4]. Group 3: Production and Distribution - The plan suggests exploring pilot projects for segmented production of chemical raw materials and biological products, as well as reforming the regulatory model for imported experimental animals [5]. - It aims to improve the convenience of customs clearance for medical and research materials, leveraging Jiangsu's strengths in biopharmaceutical innovation [5]. Group 4: Financial Support and Investment - The plan highlights the need for enhanced financial support, allowing qualified biopharmaceutical companies to list on various stock exchanges and issue bonds for financing [7]. - It encourages the establishment of investment funds specifically for the biopharmaceutical industry and supports the issuance of real estate investment trusts (REITs) for eligible projects [7]. Group 5: Data Management and Cross-Border Flow - The plan addresses concerns regarding cross-border data flow in the biopharmaceutical sector, proposing the development of a negative list for data export in this field [8]. - The establishment of a public service platform for data export safety is also part of the initiative, which aims to facilitate efficient data management for enterprises [8].

Core Points - The State Council has issued a notification to promote 77 pilot measures for comprehensive alignment with international high-standard economic and trade rules in free trade zones [1][2] - The measures cover seven areas including service trade, goods trade, digital trade, intellectual property protection, government procurement reform, post-border management reform, and risk prevention [1] - A total of 34 measures will be replicated in other free trade zones, while 43 measures will be promoted nationwide [1] Group 1 - The notification emphasizes the innovation of digital RMB application scenarios and the optimization of cross-border capital management policies for multinational companies [1] - It aims to establish a negative list for data export and promote the use of electronic bills, enhancing the three-party mechanism for labor relations [1] - The overall plan for high-level institutional opening in the China (Shanghai) Free Trade Zone will be issued in November 2023, supporting the zone in aligning with international high standards [1][2] Group 2 - The notification calls for the implementation of a free trade zone enhancement strategy, leveraging the institutional opening pilot experience from Shanghai [2] - It highlights the importance of promoting pilot measures that are urgently needed by enterprises and the public, aiming to release the dividends of institutional innovation on a larger scale [2] - The initiative is expected to drive deep reforms and high-quality development through high-level opening [2]

Core Viewpoint - The Ministry of Commerce supports the establishment of a negative list for data export in free trade zones, aimed at facilitating efficient and secure cross-border data flow for enterprises [1] Group 1: Policy Measures - The recent announcement includes 77 pilot measures that cover a wide range of areas and demonstrate significant openness [1] - The Ministry of Commerce plans to accelerate the implementation of these measures to ensure they yield effective results [1] Group 2: Data Export Regulations - The negative list for data export will allow data outside the list to be exported without the need for safety assessments, standard contracts, or protective certifications [1] - This initiative is designed to meet the cross-border data flow needs of enterprises, promoting efficient and secure data movement [1]

Group 1 - Beijing is focusing on the medical sector's needs by developing a second negative list for medical devices, following the first list that included five fields [1] - The city has established a comprehensive reform system for cross-border data flow, aiming to upgrade from the initial version to a more efficient and secure model [1][2] - The second negative list will include five sectors: medical devices, intelligent connected vehicles, trade logistics, banking, and public funds, expanding the coverage of the policy [2] Group 2 - A pilot program for the negative list will be implemented on a case-by-case basis for medical enterprises, with several companies already expressing interest in participation [3] - The focus will be on enhancing data flow for research collaboration, drug development, and multi-center consultations, encouraging partnerships between local hospitals and multinational pharmaceutical companies [3]